Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -21.73%5.18B | -38.17%2.92B | -10.59%1.95B | -15.18%9.63B | -5.59%6.62B | 8.22%4.73B | 10.51%2.18B | -1.67%11.35B | -8.74%7.01B | -13.30%4.37B |
| Refunds of taxes and levies | 53.80%168.4M | -60.99%42.28M | -81.07%1.34M | -30.69%43.15M | 157.21%109.49M | 168.67%108.36M | -26.37%7.09M | 13.80%62.25M | -16.86%42.57M | -14.62%40.33M |
| Cash received relating to other operating activities | -12.95%809.55M | -32.22%619.05M | -47.78%109.11M | 4.17%1.26B | 18.91%929.95M | 62.76%913.3M | 1.45%208.94M | 6.45%1.21B | 29.77%782.06M | 39.84%561.14M |
| Cash inflows from operating activities | -19.58%6.16B | -37.66%3.58B | -14.04%2.06B | -13.40%10.93B | -2.26%7.66B | 15.68%5.75B | 9.50%2.4B | -0.88%12.62B | -6.00%7.83B | -9.43%4.97B |
| Goods services cash paid | -12.90%3.81B | -16.01%2.59B | -35.32%1.12B | -4.88%6.19B | -1.31%4.38B | -8.01%3.09B | -18.98%1.74B | -11.61%6.51B | -13.88%4.44B | -0.11%3.36B |
| Staff behalf paid | -4.05%1.43B | -13.16%913.04M | -17.30%527.43M | 7.92%2.37B | 22.36%1.49B | 23.16%1.05B | 38.78%637.73M | 20.79%2.2B | 0.18%1.22B | 2.52%853.73M |
| All taxes paid | -56.95%236.96M | -56.68%173.37M | -35.79%71.9M | 73.57%576.41M | 117.35%550.38M | 108.23%400.21M | 36.21%111.98M | -6.59%332.09M | -26.68%253.22M | -36.11%192.2M |
| Cash paid relating to other operating activities | -23.66%958.52M | -16.77%705.81M | 85.31%899.92M | -2.92%1.39B | 47.72%1.26B | 79.12%848.03M | 84.07%485.62M | 28.62%1.43B | -11.95%850.05M | -10.64%473.43M |
| Cash outflows from operating activities | -16.11%6.44B | -18.59%4.39B | -11.76%2.62B | 0.57%10.53B | 13.57%7.67B | 10.49%5.39B | 0.77%2.97B | -1.70%10.47B | -11.99%6.76B | -2.94%4.88B |
| Net cash flows from operating activities | -1,521.58%-280.34M | -321.09%-801.01M | 2.27%-561.18M | -81.35%401.38M | -101.61%-17.29M | 283.20%362.3M | 24.39%-574.2M | 3.29%2.15B | 64.01%1.08B | -79.63%94.55M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -47.52%659.38M | -62.11%400.89M | -33.91%356.25M | 37.78%7.88B | -54.54%1.26B | -60.32%1.06B | -56.19%539.03M | 11.92%5.72B | -24.85%2.76B | 2.92%2.67B |
| Cash received from returns on investments | 440.82%215.68M | 347.25%135.15M | 120.33%42.05M | 137.47%324.01M | -56.76%39.88M | -34.28%30.22M | 26.72%19.08M | -72.80%136.44M | -9.48%92.23M | 30.12%45.98M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 854.53%26.51M | 2,147.76%26.21M | 4,021.64%1.08M | 342.27%38.43M | 205.90%2.78M | 40.52%1.17M | -75.39%26.24K | 1,413.85%8.69M | 92.82%908.02K | 160.88%829.95K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.80%159.39K | ---- | ---- |
| Cash inflows from investing activities | -30.60%901.57M | -48.39%562.26M | -28.45%399.38M | 40.55%8.24B | -54.53%1.3B | -59.85%1.09B | -55.19%558.14M | 3.00%5.86B | -26.02%2.86B | 0.20%2.71B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -3.02%169.59M | -15.66%121.93M | -20.58%71.26M | 49.67%405.43M | 34.75%174.88M | 52.23%144.57M | 96.35%89.73M | 81.13%270.88M | 29.17%129.78M | 119.04%94.97M |
| Cash paid to acquire investments | -70.73%2.41B | -57.32%2.34B | 464.59%2.59B | 63.20%13.25B | 29.17%8.22B | 20.71%5.49B | -67.30%458.4M | 60.15%8.12B | 92.92%6.36B | 94.52%4.54B |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | --289.42M | --289.77M | --289.77M | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | -97.82%10.12K | ---- | ---- | ---- | --464.37K | ---- | ---- |
| Cash outflows from investing activities | -70.34%2.57B | -58.39%2.46B | 385.17%2.66B | 66.21%13.94B | 33.74%8.68B | 27.60%5.92B | -62.14%548.12M | 60.76%8.39B | 91.04%6.49B | 94.97%4.64B |
| Net cash flows from investing activities | 77.33%-1.67B | 60.65%-1.9B | -22,649.52%-2.26B | -125.77%-5.7B | -103.15%-7.38B | -150.79%-4.83B | 104.96%10.02M | -632.43%-2.53B | -883.09%-3.63B | -686.25%-1.93B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -26.17%13.88M | -26.38%13.84M | -25.09%13.82M | 78.64%25.01M | 683.33%18.8M | --18.8M | 871.23%18.45M | -69.10%14M | -94.44%2.4M | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | -26.17%13.88M | -26.38%13.84M | -25.09%13.82M | 78.64%25.01M | 683.33%18.8M | --18.8M | 871.23%18.45M | -69.10%14M | -94.44%2.4M | ---- |
| Cash from borrowing | -2.40%5.81B | 1.96%4.06B | -20.63%3.13B | -10.72%6.27B | -8.54%5.95B | -20.59%3.98B | 16.18%3.95B | -31.97%7.02B | -27.01%6.51B | -39.72%5.01B |
| Cash received relating to other financing activities | 423.67%153.81M | -52.53%13.94M | 19.99%11.9M | 319.64%251.55M | 164.88%29.37M | 164.88%29.37M | -10.55%9.92M | -52.54%59.94M | -73.15%11.09M | -73.15%11.09M |
| Cash inflows from financing activities | -0.39%5.98B | 1.43%4.08B | -20.55%3.16B | -7.75%6.55B | -7.99%6B | -19.81%4.03B | 16.57%3.98B | -32.38%7.1B | -27.54%6.52B | -39.92%5.02B |
| Borrowing repayment | 43.74%6.63B | 5.93%4.33B | 242.01%3.17B | -0.63%6.69B | 15.42%4.62B | 138.93%4.08B | -41.19%928M | -29.86%6.74B | -35.52%4B | -66.37%1.71B |
| Dividend interest payment | -46.37%615.72M | -46.84%597.49M | -42.47%20.12M | 0.01%1.17B | -0.69%1.15B | 1.80%1.12B | -25.42%34.98M | 5.12%1.17B | 7.01%1.16B | 7.20%1.1B |
| -Including:Cash payments for dividends or profit to minority shareholders | 21.50%3.4M | -23.20%1.52M | ---- | -40.00%6.86M | -87.20%2.8M | -88.96%1.98M | -99.88%19.95K | -76.77%11.44M | --21.88M | --17.89M |
| Cash payments relating to other financing activities | 266.20%302.93M | 559.44%291.11M | 3,010.75%280.3M | 33.15%122.01M | 80.37%82.72M | 40.29%44.15M | -92.87%9.01M | 35.72%91.63M | 7.25%45.86M | 60.77%31.47M |
| Cash outflows from financing activities | 29.19%7.55B | -0.71%5.21B | 257.44%3.47B | -0.15%7.99B | 12.41%5.85B | 84.62%5.25B | -44.50%971.99M | -25.83%8B | -28.99%5.2B | -53.60%2.84B |
| Net cash flows from financing activities | -1,117.52%-1.58B | 7.73%-1.13B | -110.43%-313.62M | -59.64%-1.44B | -88.28%154.81M | -156.37%-1.23B | 80.92%3.01B | -209.79%-902.61M | -21.19%1.32B | -2.22%2.18B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -231.40%-1.44M | -107.28%-136.89K | -112.04%-176.86K | -64.14%1.13M | -36.13%1.1M | 529.61%1.88M | 142.13%1.47M | -78.41%3.15M | -94.17%1.72M | -98.49%298.82K |
| Net increase in cash and cash equivalents | 51.26%-3.53B | 32.65%-3.83B | -228.29%-3.13B | -429.63%-6.74B | -486.75%-7.24B | -1,753.67%-5.69B | 250.78%2.44B | -155.79%-1.27B | -143.68%-1.23B | -88.67%344.21M |
| Add:Begin period cash and cash equivalents | -52.32%6.14B | -52.32%6.14B | -52.32%6.14B | -8.99%12.88B | 0.05%12.88B | 0.05%12.88B | 0.05%12.88B | 33.61%14.16B | 21.53%12.88B | 21.53%12.88B |
| End period cash equivalent | -53.68%2.61B | -67.89%2.31B | -80.38%3.01B | -52.32%6.14B | -51.55%5.64B | -45.60%7.19B | 12.92%15.33B | 0.05%12.88B | -13.26%11.64B | -3.02%13.22B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.